Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-04

Clinical Trial Update: A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy

View source ↗

Summary

A trial update describing ongoing recruitment for a comparative study of speech perception in cochlear implant users vs. DFNB9 patients receiving otoferlin gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTOF gene therapy (investigational) (otoferlin gene therapy)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Hearing Loss, Genetic Disease | Status: RECRUITING